Technical Analysis for VRNA - Verona Pharma plc
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| See historical VRNA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Narrow Range Bar | Range Contraction | 7.59% | |
| New 52 Week Closing Low | Bearish | 7.59% | |
| Narrow Range Bar | Range Contraction | 7.59% | |
| Gapped Down | Weakness | 4.76% | |
| Slingshot Bearish | Bearish Swing Setup | 0.24% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
- Sector: Healthcare
- Industry: Biotechnology
Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The companys lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
Medical Specialties Respiratory Therapy Asthma Cystic Fibrosis Chronic Obstructive Pulmonary Disease Respiratory Diseases Lactams Pulmonology Treatment Of Chronic Obstructive Pulmonary Disease
Medical Specialties Respiratory Therapy Asthma Cystic Fibrosis Chronic Obstructive Pulmonary Disease Respiratory Diseases Lactams Pulmonology Treatment Of Chronic Obstructive Pulmonary Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more VRNA news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 13.47 |
| 52 Week Low | 3.65 |
| Average Volume | 4,044 |
| 200-Day Moving Average | 5.7499 |
| 50-Day Moving Average | 4.3516 |
| 20-Day Moving Average | 4.3007 |
| 10-Day Moving Average | 4.0777 |
| Average True Range | 0.2746 |
| ADX | 20.83 |
| +DI | 21.8524 |
| -DI | 28.97 |
| Chandelier Exit (Long, 3 ATRs ) | 4.0262 |
| Chandelier Exit (Short, 3 ATRs ) | 4.5938 |
| Upper Bollinger Band | 4.8792 |
| Lower Bollinger Band | 3.7222 |
| Percent B (%b) | 0.46 |
| BandWidth | 26.902597 |
| MACD Line | -0.094 |
| MACD Signal Line | -0.094 |
| MACD Histogram | 0.0 |
| Fundamentals | Value |
|---|---|
| Market Cap | 47.02 Million |
| Num Shares | 11.1 Million |
| EPS | -1.51 |
| Price-to-Earnings (P/E) Ratio | -2.81 |
| Price-to-Sales | 0.00 |
| Price-to-Book | 1.25 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.27 | ||||
| Resistance 3 (R3) | 4.26 | 4.26 | 4.26 | ||
| Resistance 2 (R2) | 4.26 | 4.25 | 4.26 | 4.26 | |
| Resistance 1 (R1) | 4.25 | 4.25 | 4.26 | 4.26 | 4.26 |
| Pivot Point | 4.25 | 4.25 | 4.25 | 4.25 | 4.25 |
| Support 1 (S1) | 4.24 | 4.24 | 4.25 | 4.25 | 4.24 |
| Support 2 (S2) | 4.24 | 4.24 | 4.24 | 4.24 | |
| Support 3 (S3) | 4.23 | 4.24 | 4.24 | ||
| Support 4 (S4) | 4.24 |
